Intech Investment Management LLC reduced its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 25.9% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 69,653 shares of the company’s stock after selling 24,360 shares during the quarter. Intech Investment Management LLC’s holdings in Tenet Healthcare were worth $17,801,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. V Square Quantitative Management LLC purchased a new stake in shares of Tenet Healthcare during the third quarter worth about $26,000. Mather Group LLC. raised its position in shares of Tenet Healthcare by 126.9% in the 3rd quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after purchasing an additional 66 shares during the last quarter. MADDEN SECURITIES Corp purchased a new position in shares of Tenet Healthcare in the 3rd quarter valued at approximately $38,000. Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the 2nd quarter worth approximately $37,000. Finally, Fortitude Family Office LLC boosted its stake in Tenet Healthcare by 52.1% in the 3rd quarter. Fortitude Family Office LLC now owns 222 shares of the company’s stock worth $57,000 after purchasing an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.
Tenet Healthcare Price Performance
Shares of NYSE:THC opened at $286.34 on Monday. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $301.44. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 1.76. The company has a market cap of $22.79 billion, a PE ratio of 8.30, a price-to-earnings-growth ratio of 1.53 and a beta of 1.20. The company’s 50 day moving average is $267.83 and its 200 day moving average is $224.88.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating the consensus estimate of $4.68 by $1.96. The business had revenue of $6.28 billion for the quarter, compared to the consensus estimate of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The business’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same period in the prior year, the firm earned $3.70 EPS. On average, sell-side analysts forecast that Tenet Healthcare Corporation will post 22.32 EPS for the current year.
Insider Buying and Selling at Tenet Healthcare
In related news, CEO Saumya Sutaria sold 50,000 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the completion of the transaction, the chief executive officer directly owned 483,564 shares in the company, valued at $134,774,122.44. The trade was a 9.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director J. Robert Kerrey sold 12,010 shares of Tenet Healthcare stock in a transaction on Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the transaction, the director directly owned 4,794 shares of the company’s stock, valued at $1,264,273.68. The trade was a 71.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 99,462 shares of company stock worth $27,081,234. Insiders own 0.97% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on THC. TD Cowen upped their price target on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Mizuho set a $305.00 price objective on shares of Tenet Healthcare in a research note on Monday, November 2nd. Stephens reissued an “overweight” rating and set a $285.00 price objective on shares of Tenet Healthcare in a report on Monday, July 27th. UBS Group upped their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Finally, Leerink Partners raised their target price on Tenet Healthcare from $309.00 to $342.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $296.65.
Check Out Our Latest Research Report on Tenet Healthcare
About Tenet Healthcare
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Further Reading
- Five stocks we like better than Tenet Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
